150 related articles for article (PubMed ID: 15262835)
1. TIMP-3 deficiency leads to dilated cardiomyopathy.
Fedak PW; Smookler DS; Kassiri Z; Ohno N; Leco KJ; Verma S; Mickle DA; Watson KL; Hojilla CV; Cruz W; Weisel RD; Li RK; Khokha R
Circulation; 2004 Oct; 110(16):2401-9. PubMed ID: 15262835
[TBL] [Abstract][Full Text] [Related]
2. Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice.
Kassiri Z; Oudit GY; Sanchez O; Dawood F; Mohammed FF; Nuttall RK; Edwards DR; Liu PP; Backx PH; Khokha R
Circ Res; 2005 Aug; 97(4):380-90. PubMed ID: 16037568
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy.
Fedak PW; Moravec CS; McCarthy PM; Altamentova SM; Wong AP; Skrtic M; Verma S; Weisel RD; Li RK
Circulation; 2006 Jan; 113(2):238-45. PubMed ID: 16401770
[TBL] [Abstract][Full Text] [Related]
4. TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
Tian H; Cimini M; Fedak PW; Altamentova S; Fazel S; Huang ML; Weisel RD; Li RK
J Mol Cell Cardiol; 2007 Dec; 43(6):733-43. PubMed ID: 17945252
[TBL] [Abstract][Full Text] [Related]
5. Placental growth factor regulates cardiac inflammation through the tissue inhibitor of metalloproteinases-3/tumor necrosis factor-α-converting enzyme axis: crucial role for adaptive cardiac remodeling during cardiac pressure overload.
Carnevale D; Cifelli G; Mascio G; Madonna M; Sbroggiò M; Perrino C; Persico MG; Frati G; Lembo G
Circulation; 2011 Sep; 124(12):1337-50. PubMed ID: 21900081
[TBL] [Abstract][Full Text] [Related]
6. Matrix Metalloproteinases MMP-1 and MMP-9 and Their Inhibitor TIMP-1 as Markers of Dilated Cardiomyopathy in Patients of Different Age.
Antonov IB; Kozlov KL; Pal'tseva EM; Polyakova OV; Lin'kova NS
Bull Exp Biol Med; 2018 Mar; 164(4):550-553. PubMed ID: 29504111
[TBL] [Abstract][Full Text] [Related]
7. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy].
Pauschinger M; Chandrasekharan K; Li J; Schwimmbeck PL; Noutsias M; Schultheiss HP
Herz; 2002 Nov; 27(7):677-82. PubMed ID: 12439639
[TBL] [Abstract][Full Text] [Related]
9. Opposing roles of PARP-1 in MMP-9 and TIMP-2 expression and mast cell degranulation in dyslipidemic dilated cardiomyopathy.
Hans CP; Feng Y; Naura AS; Troxclair D; Zerfaoui M; Siddiqui D; Jihang J; Kim H; Kaye AD; Matrougui K; Lazartigues E; Boulares AH
Cardiovasc Pathol; 2011; 20(2):e57-68. PubMed ID: 20434371
[TBL] [Abstract][Full Text] [Related]
10. Canine Dilated Cardiomyopathy: Diffuse Remodeling, Focal Lesions, and the Involvement of Macrophages and New Vessel Formation.
Gasparini S; Fonfara S; Kitz S; Hetzel U; Kipar A
Vet Pathol; 2020 May; 57(3):397-408. PubMed ID: 32125251
[TBL] [Abstract][Full Text] [Related]
11. Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system.
Pauschinger M; Chandrasekharan K; Schultheiss HP
Heart Fail Rev; 2004 Jan; 9(1):21-31. PubMed ID: 14739765
[TBL] [Abstract][Full Text] [Related]
12. Cardiomyocyte-enriched protein CIP protects against pathophysiological stresses and regulates cardiac homeostasis.
Huang ZP; Kataoka M; Chen J; Wu G; Ding J; Nie M; Lin Z; Liu J; Hu X; Ma L; Zhou B; Wakimoto H; Zeng C; Kyselovic J; Deng ZL; Seidman CE; Seidman JG; Pu WT; Wang DZ
J Clin Invest; 2015 Nov; 125(11):4122-34. PubMed ID: 26436652
[TBL] [Abstract][Full Text] [Related]
13. Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3.
Fedak PW; Altamentova SM; Weisel RD; Nili N; Ohno N; Verma S; Lee TY; Kiani C; Mickle DA; Strauss BH; Li RK
Am J Physiol Heart Circ Physiol; 2003 Feb; 284(2):H626-34. PubMed ID: 12388270
[TBL] [Abstract][Full Text] [Related]
14. MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure.
Givvimani S; Tyagi N; Sen U; Mishra PK; Qipshidze N; Munjal C; Vacek JC; Abe OA; Tyagi SC
Arch Physiol Biochem; 2010 May; 116(2):63-72. PubMed ID: 20230216
[TBL] [Abstract][Full Text] [Related]
15. Ectopic trypsin in the myocardium promotes dilated cardiomyopathy after influenza A virus infection.
Pan HY; Sun HM; Xue LJ; Pan M; Wang YP; Kido H; Zhu JH
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(6):H922-32. PubMed ID: 25038143
[TBL] [Abstract][Full Text] [Related]
16. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function.
Lindsey ML; Goshorn DK; Squires CE; Escobar GP; Hendrick JW; Mingoia JT; Sweterlitsch SE; Spinale FG
Cardiovasc Res; 2005 May; 66(2):410-9. PubMed ID: 15820210
[TBL] [Abstract][Full Text] [Related]
18. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
[TBL] [Abstract][Full Text] [Related]
19. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.
Li YY; Feng YQ; Kadokami T; McTiernan CF; Draviam R; Watkins SC; Feldman AM
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12746-51. PubMed ID: 11070088
[TBL] [Abstract][Full Text] [Related]
20. Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.
Angoulvant D; Fazel S; Weisel RD; Lai TY; Fedak PW; Chen L; Rafati S; Seneviratne CK; Degousee N; Li RK
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):471-80. PubMed ID: 19185172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
